8-K
Current Report
Jasper Therapeutics, Inc. Filed Acc 0001213900-26-060029
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea0291168-8k_jasper.htm…